// App-Quantinova.ai

: Post-Transplant Cyclophosphamide, Abatacept and Short Course of Tacrolimus (CAST) for Graft-Versus-Host Disease Prevention Following Haploidentical Peripheral Blood Stem Cell Transplantation

Researchers

Presenter

  • A Samer Al-Homsi

Principal Investigators

  • Frank Cirrone

  • Kelli Cole

  • Jaime Andres Suarez-Londono

  • Sharon L. Gardner

  • Jingmei Hsu

  • Stephanie Wo

  • Kelsey Stocker

  • Benedetto Bruno

  • Judith Goldberg

  • Benjamin Levinson

  • Maher Abdul-Hay

Medical Centers

  • Blood and Marrow Transplantation and Cellular Therapy, New York University Langone Health, New York, NY

  • Division of Pediatric Hematology and Oncology, Stephen D. Hassenfeld Children's Center for Cancer and Blood Disorders, NYU Langone Health, New York, NY

  • Division of Hematoloty, University of Torino, Torino, Italy

  • Department of Biostatistics, NYU Grossman School of Medicine, New York, NY

Locations

  • United States

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Autoimmune (AI)

Disease

  • Hematological malignancies

  • Graft-versus-host disease

Biomarkers

  • Granulocyte colony-stimulating factor

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Letermovir

  • Tacrolimus

  • Abatacept

  • Filgrastim

Outcome

  • N/A

Study Design

  • Prospective

  • Single Center

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved